GALT
Galectin·NASDAQ
--
--(--)
--
--(--)
GALT fundamentals
Galectin (GALT) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.12 (YoY +40.00%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.12
+40.00%
Report date
Aug 14, 2025
Earnings Call
8:00 AM on Aug 14, 2025
Meeting link.EPS
Actual | -0.06 | -0.11 | -0.1 | -0.14 | -0.11 | -0.15 | -0.14 | -0.12 | -0.17 | -0.16 | -0.14 | -0.18 | -0.19 | -0.15 | -0.24 | -0.16 | -0.19 | -0.2 | -0.18 | -0.19 | -0.15 | -0.12 | ||||||||||
Forecast | -0.08 | -0.07 | -0.11 | -0.12 | -0.13 | -0.13 | -0.13 | -0.14 | -0.1 | -0.14 | -0.2 | -0.17 | -0.14 | -0.14 | -0.1 | -0.1 | -0.16 | -0.16 | -0.2 | -0.16 | -0.2 | -0.16 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +25.00% | -57.14% | +9.09% | -16.67% | +15.38% | -15.38% | -7.69% | +14.29% | -70.00% | -14.29% | +30.00% | -5.88% | -35.71% | -7.14% | -140.00% | -60.00% | -18.75% | -25.00% | +10.00% | -18.75% | +25.00% | +25.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Galectin’s earnings call?What is Galectin's latest dividend and current dividend yield?Did Galectin beat or miss consensus estimates last quarter?What factors drove the changes in Galectin's revenue and profit?What guidance did Galectin's management provide for the next earnings period?What is Galectin's gross profit margin?What does Galectin do and what are its main business segments?What were the key takeaways from Galectin's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
